CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-14 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +2,160 | $3.95 | $9K | 252,605 |
| 2022-10-14 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,160 | $39.41 | $85K | 250,445 |
| 2022-10-14 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −540 | $39.41 | $21K | 190,737 |
| 2022-10-14 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −2,160 | 1,492,113 | ||
| 2022-10-14 | Schlanger David J Executive Chairman | Exercise or conversion | +1,850 | $0.91 | $2K | 84,398 |
| 2022-10-14 | Schlanger David J Executive Chairman | Sale | −1,850 | $39.41 | $73K | 82,548 |
| 2022-10-14 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −1,850 | 1,420,628 | ||
| 2022-10-13 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +240 | $3.95 | $948 | 250,685 |
| 2022-10-13 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −240 | $39.45 | $9K | 250,445 |
| 2022-10-13 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −60 | $39.45 | $2K | 191,277 |
| 2022-10-13 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −240 | 1,494,273 | ||
| 2022-10-13 | Schlanger David J Executive Chairman | Exercise or conversion | +400 | $0.91 | $364 | 82,948 |
| 2022-10-13 | Schlanger David J Executive Chairman | Sale | −400 | $39.46 | $16K | 82,548 |
| 2022-10-13 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −400 | 1,422,478 | ||
| 2022-10-13 | Payson Norman Director | Sale | −1,700 | $36.74 | $62K | 343,533 |
| 2022-10-13 | Payson Norman Director | Sale | −630 | $38.33 | $24K | 342,903 |
| 2022-10-13 | Payson Norman Director | Sale | −4,287 | $39.00 | $167K | 338,616 |
| 2022-10-12 | Payson Norman Director | Sale | −6,217 | $38.35 | $238K | 345,633 |
| 2022-10-12 | Payson Norman Director | Sale | −400 | $38.79 | $16K | 345,233 |
| 2022-10-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +19,602 | $3.95 | $77K | 270,047 |
Page 41 of 77 · 1,524 trades